NJ ACTS Diversity and Re-entry/Re-integration Supplements for Junior Faculty (Instructor and Assistant Professor) Program Information NJ ACTS (New Jersey Alliance for Clinical and Translational Research) is designed to improve the translational research process to get more treatments to more patients more quickly. Funded by NIH/NCATS under the Clinical and Translational Science Awards (CTSA) Program, NJ ACTS brings together Rutgers University, Princeton University and New Jersey Institute of Technology as the academic partners in the CTSA, and it works with NCATS and other CTSA’s on a national level. NJ ACTS acts as a catalyst for innovation in training, research tools and processes.
The purpose of this announcement is to alert you to the CTSA Program’s recently announced solicitation for diversity and re-entry/re-integration research supplements for junior faculty. The program creates opportunities for diversity in health-related research and reentry/re-integration into biomedical, behavioral, clinical, translational or social science research careers by providing career development funding.
At a Glance
Internal Submission (pre-proposals) Deadline: September 24, 2021 [NIH Deadline: November 1, 2021]
Candidates: Citizens or non-citizen nationals of the U.S. or individuals who have been lawfully admitted for permanent residence in the U.S. and meet the eligibility criteria described in the funding opportunity announcements.
Award Budget: Up to $100,000/year for salary, plus fringe benefits. Costs may not exceed $150,000 direct costs after including funds for travel and limited supplies. The budget is based on the NIH RFA.